Table 2.
Result of FoundationACT™ in a 34-year-old female former smoker with advanced lung adenocarcinoma
| Blood (collected and submitted in 2016) | |
| Alterations | Mutation allele frequency |
| MET 3028+2T>C (splice site mutation) | 0.19% |
| BRCA2 L3061* | 50.7% |
Result of FoundationACT™ in a 34-year-old female former smoker with advanced lung adenocarcinoma
| Blood (collected and submitted in 2016) | |
| Alterations | Mutation allele frequency |
| MET 3028+2T>C (splice site mutation) | 0.19% |
| BRCA2 L3061* | 50.7% |